Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes

被引：9

作者：

Bolli, Geremia B. ^{[1
]}

Porcellati, Francesca ^{[1
]}

Lucidi, Paola ^{[1
]}

Fanelli, Carmine G. ^{[1
]}

机构：

[1] Univ Perugia, Dept Internal Med, Sect Internal Med Endocrinol & Metab, I-06100 Perugia, Italy

来源：

DIABETES CARE | 2011年 / 34卷

关键词：

BETA-CELL FUNCTION; NPH INSULIN; GLYCEMIC CONTROL; PEPTIDE-1; ANALOG; LOWERING DRUGS; NAIVE PEOPLE; LIVER FAT; ADD-ON; GLARGINE; THERAPY;

D O I：

10.2337/dc11-s224

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S220 / S224

页数：5

共 45 条

[1]

[Anonymous], 1995, Diabetes, V44, P1249

[2] Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin A proof-of-concept study [J].

Arnolds, Sabine ;

Dellweg, Sibylle ;

Clair, Janina ;

Dain, Marie-Paule ;

Nauck, Michael A. ;

Rave, Klaus ;

Kapitza, Christoph .

DIABETES CARE, 2010, 33 (07) :1509-1515

[3] Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial [J].

Bretzel, Reinhard G. ;

Nuber, Ulrike ;

Landgraf, Wolfgang ;

Owens, David R. ;

Bradley, Clare ;

Linn, Thomas .

LANCET, 2008, 371 (9618) :1073-1084

[4] One-year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients A randomized, controlled trial [J].

Bunck, Mathijs C. ;

Diamant, Michaela ;

Corner, Anja ;

Eliasson, Bjorn ;

Malloy, Jaret L. ;

Shaginian, Rimma M. ;

Deng, Wei ;

Kendall, David M. ;

Taskinen, Marja-Riitta ;

Smith, Ulf ;

Yki-Jarvinen, Hannele ;

Heine, Robert J. .

DIABETES CARE, 2009, 32 (05) :762-768

[5] Use of Twice-Daily Exenatide in Basal Insulin-Treated Patients With Type 2 Diabetes A Randomized, Controlled Trial [J].

Buse, John B. ;

Bergenstal, Richard M. ;

Glass, Leonard C. ;

Heilmann, Cory R. ;

Lewis, Michelle S. ;

Kwan, Anita Y. M. ;

Hoogwerf, Byron J. ;

Rosenstock, Julio .

ANNALS OF INTERNAL MEDICINE, 2011, 154 (02) :103-+

[6] Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy [J].

Ferrannini, E. ;

Fonseca, V. ;

Zinman, B. ;

Matthews, D. ;

Ahren, B. ;

Byiers, S. ;

Shao, Q. ;

Dejager, S. .

DIABETES OBESITY & METABOLISM, 2009, 11 (02) :157-166

[7] Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study [J].

Fritsche, A. ;

Larbig, M. ;

Owens, D. ;

Haering, H.-U. .

DIABETES OBESITY & METABOLISM, 2010, 12 (02) :115-123

[8] Effect of a multifactorial intervention on mortality in type 2 diabetes [J].

Gaede, Peter ;

Lund-Andersen, Henrik ;

Parving, Hans-Henrik ;

Pedersen, Oluf .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06) :580-591

[9]

Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743

[10]

Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006

← 1 2 3 4 5 →